Corcept Therapeutics

Intra-Cellular Therapies

Longboard Pharmaceuticals

Jazz Pharmaceuticals

Viatris

Bristol-Myers

Edgewise Therapeutics

Catalent

Elanco Animal Health Inc

Axsome Therapeutics

SPDR S&P Pharmaceuticals ETF

XPH tracks an equal-weighted index of US pharmaceutical companies.

iShares U.S. Industrials ETF

iShares U.S. Telecommunications ETF

SPDR S&P Bank ETF

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Retail ETF

Vanguard Financials ETF

Vanguard Telecommunication Services ETF

Zacks recently issued quarterly rank updates for ETFs and these sector ETFs have been upgraded to Buy.

5 Sector ETFs Just Got Upgraded to Buy

KraneShares MSCI All China Health Care Index ETF

VanEck Vectors Pharmaceutical ETF

The best pharmaceutical ETFs for Q3 2020 are KURE, XPH, and PPH.

Best Performing Pharmaceutical ETFs for Q3 2020

VanEck Vectors Biotech ETF

Loncar Cancer Immunotherapy ETF

First Trust NYSE Arca Biotechnology Index Fund

iShares Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

Invesco Dynamic Biotechnology & Genome ETF

Invesco DWA Healthcare Momentum ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Health Care Services ETF

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

The pharmaceutical industry is often a hotbed of takeover rumors.

Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases

First Trust Nasdaq Pharmaceuticals ETF 

Strong results led to solid trading in pharma ETFs over the past week.

Pharma ETFs Gain on Healthy Q4 Earnings

SPDR Gold Trust

SPDR Gold MiniShares Trust

iShares iBoxx $ Investment Grade Corporate Bond ETF

Invesco QQQ

ProShares Short VIX Short-Term Futures ETF

In a market that has been steadily climbing despite impeachment proceedings against President Trump, a roller-coaster ride due to tariffs and a trade war with China, and generalized global uncertainty, volatility has become relatively complacent.

Could A More Significant Volatility Breakout Be Underway?

Mylan

Novartis

Pfizer

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Teva Pharmaceutical

The Trouble With Pharma

Virtus LifeSci Biotech Clinical Trials ETF

PowerShares DWA NASDAQ Momentum Portfolio

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

Global X Genomics & Biotechnology ETF

iShares U.S. Oil Equipment & Services ETF

Invesco Dynamic Oil & Gas Services ETF

Global X Silver Miners ETF

Amplify Junior Silver Miners ETF

VanEck Vectors Semiconductor ETF

iShares PHLX Semiconductor ETF

SPDR S&P Semiconductor ETF

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

4 Sector ETFs That Beat the Market in Q4

First Trust Dow Jones Internet Index Fund

Johnson & Johnson

Merck

iShares MSCI USA Quality Factor ETF

Invesco S&P 500 Low Volatility ETF

SPDR S&P 500 ETF Trust

iShares Edge MSCI Min Vol USA ETF

SPDR S&P Biotech ETF

Utilities Select Sector SPDR Fund

Health Care Select Sector SPDR Fund

Another bout of sector rotation seems to be underway as investors shed defensive holdings for more aggressive positions.

Quality Play With Pharma ETFs

Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year.

Could Coiled Volatility Suggest A Bigger Stock Move Is Coming?

Journey Medical Corp

GlycoMimetics

Ironwood Pharma

Rigel Pharmaceuticals

Pharma sector wins in October, making these ETFs and stocks winners.

Pharma Sector Tops in October: Best ETFs & Stocks

Robust results led to solid trading in pharma ETFs in a month.

Pharma ETFs Set to Benefit Post Strong Q3 Earnings

The healthcare sector, which has been the second-worst performer among the 11 major S&P 500 sectors this year, took the center stage this month with some outperformance compared to other sectors.

Healthcare ETFs Win in October: Here's Why

Despite robust results, pharma ETFs have been trending downward in a month.

Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

AbbVie

Bayer AG

GlaxoSmithKline

Eli Lilly

Roche Holding AG

Sanofi

"We're working on it right now a favored nations clause where we pay the lower nation's price is, like Canada," President Donald Trump tells reporters.

Trump says administration preparing an executive order on drug prices

Despite such robust results, pharma ETFs have been trending downward in a month.

Pharma ETFs Down Despite Solid Q1 Results

Recent comments by UnitedHealthcare highlighted the risk of health care reform.

Health Care Funds To Avoid

News for SPDR S&P Pharmaceuticals ETF ETF (XPH)